	US 11,903,992 B2
	Composition comprising lidocaine, l-carnosine and dexpanthenol
Mahesh Kandula, Andhra Pradesh (IN)
Assigned to Cellix Bio Private Limited, Hyderabad (IN)
Filed by Cellix Bio Private Limited, Hyderabad (IN)
Filed on Feb. 10, 2022, as Appl. No. 17/650,664.
Application 17/650,664 is a continuation of application No. PCT/IB2022/050058, filed on Jan. 5, 2022.
Claims priority of application No. 202141003284 (IN), filed on Jan. 23, 2021; application No. 202141006680 (IN), filed on Feb. 17, 2021; application No. 202141016620 (IN), filed on Apr. 8, 2021; and application No. 202141048439 (IN), filed on Oct. 24, 2021.
Prior Publication US 2022/0233629 A1, Jul. 28, 2022
Int. Cl. A61K 38/05 (2006.01); A61K 31/167 (2006.01); A61K 31/164 (2006.01); A61K 31/728 (2006.01); A61K 47/12 (2006.01); A61K 9/00 (2006.01); A61K 47/18 (2017.01); A61K 47/02 (2006.01); A61K 47/32 (2006.01); A61K 47/10 (2017.01); A61K 47/26 (2006.01)

CPC A61K 38/05 (2013.01) [A61K 9/006 (2013.01); A61K 31/164 (2013.01); A61K 31/167 (2013.01); A61K 31/728 (2013.01); A61K 47/02 (2013.01); A61K 47/10 (2013.01); A61K 47/12 (2013.01); A61K 47/186 (2013.01); A61K 47/26 (2013.01); A61K 47/32 (2013.01)]

16 Claims

1. A composition comprising: lidocaine, or a salt or a hydrate or a solvate thereof, L-Carnosine, or a salt or a hydrate or a solvate thereof; and dexpanthenol; or a salt or a hydrate or a solvate thereof, wherein said composition is formulated as an oral formulation; and wherein the composition further comprises at least one excipient that is a fatty acid derivative selected from a group consisting of diglyceryl lauryl fumarate, diglyceryl lauryl succinate, diglyceryl capryl succinate, and any combination thereof.